The study highlights how color vision deficiency can delay bladder cancer diagnosis, increasing mortality risk and ...

2026年美国临床肿瘤学会泌尿生殖系统肿瘤研讨会（ASCO GU ...

A large U.S. health records study suggests that difficulty seeing blood in urine may put color-blind patients at higher risk.

People with color blindness may be less able to spot an early sign of bladder cancer, making them likelier to be diagnosed ...

Researchers have taken a look at survival rates of cancer patients who have color vision deficiency (CVD), finding that ...

A new Stanford Medicine study suggests that colorblindness may obscure one of the earliest warning signs of bladder cancer ...

The earliest symptoms of bladder cancer may go unnoticed by patients with colorblindness or similar color vision deficiencies ...

Colorblind people might have a unique disadvantage in noticing an early warning sign of certain cancers, a new study suggests.

Recognizing the sight of blood in urine, the most common first sign of bladder cancer, is often the impetus that leads people ...

Out of sight, out of mind. A new study suggests a common eye condition could be quietly masking one of the only early warning signs of bladder cancer — the 10th leading cause of cancer deaths in the ...

What Is Zusduri Used For? Zusduri is used to treat a certain type of recurrent, persistent bladder cancer known as LG-IR-NMIBC. About 75% of people with bladder cancer present with non-muscle invasive ...

Chugai files regulatory application with MHLF for additional indication of Tecentriq to treat adjuvant therapy for MRD-positive bladder cancer: Tokyo Thursday, January 29, 2026, 0 ...